$50,000 of UNITEDHEALTH GROUP lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Defense Health care and Veterans health care Veterans healthcare, Veterans disability processing Defense Health Care, National Defense Authorization Act. FY27 Defense Appropriations, FY27 Military Construction and Veteran Affairs and related Committees Appropriations"
You can find more data on corporate lobbying on Quiver Quantitative.
UNH Congressional Stock Trading
Members of Congress have traded $UNH stock 9 times in the past 6 months. Of those trades, 7 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $UNH stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARIA ELVIRA SALAZAR has traded it 3 times. They made 2 purchases worth up to $30,000 on 04/22 and 1 sale worth up to $15,000 on 06/04.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 04/14, 03/13 and 1 sale worth up to $50,000 on 02/10.
- REPRESENTATIVE RICHARD MCCORMICK purchased up to $15,000 on 03/19.
- SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 02/25.
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 02/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
UNH Hedge Fund Activity
We have seen 1,241 institutional investors add shares of UNH stock to their portfolio, and 1,626 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 12,377,403 shares (+146.6%) to their portfolio in Q1 2026, for an estimated $3,327,664,796
- CAPITAL RESEARCH GLOBAL INVESTORS added 10,850,420 shares (+173.3%) to their portfolio in Q1 2026, for an estimated $2,917,135,417
- CAPITAL INTERNATIONAL INVESTORS removed 9,653,799 shares (-51.7%) from their portfolio in Q1 2026, for an estimated $2,595,423,861
- WELLINGTON MANAGEMENT GROUP LLP removed 5,597,135 shares (-35.7%) from their portfolio in Q1 2026, for an estimated $1,504,789,744
- CAPITAL WORLD INVESTORS added 5,192,373 shares (+23.0%) to their portfolio in Q1 2026, for an estimated $1,395,969,481
- BERKSHIRE HATHAWAY INC removed 5,039,564 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,354,886,781
- ROYAL BANK OF CANADA removed 2,749,844 shares (-34.1%) from their portfolio in Q1 2026, for an estimated $739,295,559
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
UNH Analyst Ratings
Wall Street analysts have issued reports on $UNH in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 02/05/2026
- Truist Securities issued a "Buy" rating on 02/02/2026
- Barclays issued a "Overweight" rating on 01/30/2026
- Wells Fargo issued a "Overweight" rating on 01/30/2026
- Jefferies issued a "Buy" rating on 01/28/2026
- Leerink Partners issued a "Outperform" rating on 01/28/2026
To track analyst ratings and price targets for UNH, check out Quiver Quantitative's $UNH forecast page.
UNH Price Targets
Multiple analysts have issued price targets for $UNH recently. We have seen 20 analysts offer price targets for $UNH in the last 6 months, with a median target of $407.0.
Here are some recent targets:
- Sidharth Sahoo from HSBC set a target price of $380.0 on 07/06/2026
- Erin Wright from Morgan Stanley set a target price of $468.0 on 06/30/2026
- Kevin Fischbeck from B of A Securities set a target price of $475.0 on 06/24/2026
- Whit Mayo from Leerink Partners set a target price of $462.0 on 06/17/2026
- Ann Hynes from Mizuho set a target price of $460.0 on 06/08/2026
- Lisa Gill from JP Morgan set a target price of $466.0 on 06/08/2026
- David Macdonald from Truist Securities set a target price of $440.0 on 06/01/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
